Marcia C.de Castro, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brazil | 86 | 2024 | 1250 | 6.530 |
Why?
|
Malaria | 31 | 2025 | 1249 | 5.920 |
Why?
|
Dengue | 12 | 2023 | 258 | 4.580 |
Why?
|
Aedes | 6 | 2023 | 101 | 2.620 |
Why?
|
Anopheles | 10 | 2022 | 193 | 2.190 |
Why?
|
Epidemics | 9 | 2021 | 517 | 1.920 |
Why?
|
Mosquito Control | 9 | 2021 | 110 | 1.850 |
Why?
|
Malaria, Vivax | 10 | 2024 | 168 | 1.820 |
Why?
|
Insecticides | 7 | 2021 | 200 | 1.770 |
Why?
|
Child Mortality | 4 | 2020 | 204 | 1.710 |
Why?
|
Government Programs | 4 | 2023 | 278 | 1.550 |
Why?
|
Conservation of Natural Resources | 4 | 2024 | 209 | 1.510 |
Why?
|
Infant Mortality | 5 | 2020 | 754 | 1.420 |
Why?
|
Insect Vectors | 5 | 2018 | 136 | 1.390 |
Why?
|
Dengue Vaccines | 2 | 2023 | 16 | 1.340 |
Why?
|
Malaria, Falciparum | 9 | 2024 | 1077 | 1.180 |
Why?
|
Family Characteristics | 6 | 2020 | 1004 | 1.110 |
Why?
|
Travel | 7 | 2025 | 805 | 1.100 |
Why?
|
Rural Population | 9 | 2025 | 2325 | 1.080 |
Why?
|
Ecosystem | 7 | 2024 | 494 | 0.970 |
Why?
|
Environment | 4 | 2017 | 1122 | 0.950 |
Why?
|
Censuses | 4 | 2020 | 198 | 0.940 |
Why?
|
Plasmodium vivax | 8 | 2024 | 203 | 0.930 |
Why?
|
Agriculture | 3 | 2024 | 187 | 0.890 |
Why?
|
Tanzania | 13 | 2021 | 1407 | 0.870 |
Why?
|
Chagas Disease | 4 | 2022 | 166 | 0.860 |
Why?
|
Family Health | 2 | 2018 | 1255 | 0.860 |
Why?
|
Urban Population | 9 | 2025 | 2046 | 0.840 |
Why?
|
Larva | 9 | 2021 | 514 | 0.830 |
Why?
|
Emigrants and Immigrants | 2 | 2020 | 551 | 0.810 |
Why?
|
Communicable Diseases, Emerging | 2 | 2020 | 148 | 0.780 |
Why?
|
Disease Outbreaks | 7 | 2023 | 1761 | 0.770 |
Why?
|
Patient Acceptance of Health Care | 4 | 2021 | 3235 | 0.760 |
Why?
|
Tuberculosis | 7 | 2024 | 2029 | 0.740 |
Why?
|
National Health Programs | 3 | 2019 | 442 | 0.730 |
Why?
|
Pregnancy Complications, Infectious | 6 | 2020 | 2190 | 0.710 |
Why?
|
Pandemics | 12 | 2023 | 8749 | 0.700 |
Why?
|
Health Priorities | 1 | 2023 | 380 | 0.680 |
Why?
|
Poverty | 9 | 2022 | 2720 | 0.680 |
Why?
|
Disease Transmission, Infectious | 2 | 2016 | 560 | 0.670 |
Why?
|
Health Services Accessibility | 7 | 2025 | 5522 | 0.660 |
Why?
|
Humans | 152 | 2025 | 768970 | 0.660 |
Why?
|
Residence Characteristics | 7 | 2017 | 2121 | 0.650 |
Why?
|
Population Density | 6 | 2020 | 193 | 0.640 |
Why?
|
Mothers | 8 | 2024 | 2209 | 0.630 |
Why?
|
Cause of Death | 4 | 2023 | 3721 | 0.620 |
Why?
|
Health Facilities | 2 | 2020 | 577 | 0.620 |
Why?
|
Dog Diseases | 2 | 2020 | 143 | 0.610 |
Why?
|
Delivery of Health Care | 6 | 2023 | 5375 | 0.610 |
Why?
|
Leishmaniasis, Visceral | 2 | 2020 | 100 | 0.600 |
Why?
|
Emigration and Immigration | 1 | 2021 | 407 | 0.590 |
Why?
|
Life Expectancy | 2 | 2023 | 1249 | 0.590 |
Why?
|
Transients and Migrants | 1 | 2020 | 170 | 0.580 |
Why?
|
Urban Health | 1 | 2020 | 535 | 0.580 |
Why?
|
Insect Control | 2 | 2020 | 28 | 0.570 |
Why?
|
Malnutrition | 1 | 2024 | 632 | 0.570 |
Why?
|
Extraction and Processing Industry | 1 | 2016 | 10 | 0.560 |
Why?
|
Child, Preschool | 30 | 2025 | 42683 | 0.550 |
Why?
|
Infant | 29 | 2025 | 36556 | 0.530 |
Why?
|
Birth Rate | 2 | 2019 | 168 | 0.530 |
Why?
|
Haemophilus Vaccines | 1 | 2016 | 71 | 0.520 |
Why?
|
Chikungunya virus | 3 | 2022 | 56 | 0.520 |
Why?
|
Epidemiologic Methods | 2 | 2020 | 1328 | 0.510 |
Why?
|
Communicable Disease Control | 3 | 2020 | 857 | 0.500 |
Why?
|
Physicians, Primary Care | 2 | 2024 | 625 | 0.490 |
Why?
|
Abortion, Induced | 2 | 2018 | 471 | 0.490 |
Why?
|
Cost of Illness | 3 | 2024 | 1960 | 0.490 |
Why?
|
Socioeconomic Factors | 12 | 2024 | 7861 | 0.490 |
Why?
|
Breast Feeding | 6 | 2024 | 1364 | 0.480 |
Why?
|
Bacterial Capsules | 1 | 2016 | 247 | 0.480 |
Why?
|
Leishmania infantum | 1 | 2014 | 17 | 0.480 |
Why?
|
Health Policy | 6 | 2023 | 2700 | 0.480 |
Why?
|
Disease Vectors | 1 | 2014 | 61 | 0.480 |
Why?
|
Female | 81 | 2025 | 397515 | 0.460 |
Why?
|
Mosquito Nets | 1 | 2013 | 8 | 0.460 |
Why?
|
Infant, Newborn | 20 | 2024 | 26428 | 0.450 |
Why?
|
Anemia | 5 | 2024 | 1517 | 0.450 |
Why?
|
Dengue Virus | 3 | 2021 | 204 | 0.450 |
Why?
|
Young Adult | 31 | 2025 | 60131 | 0.450 |
Why?
|
Treatment Refusal | 1 | 2017 | 433 | 0.440 |
Why?
|
Adolescent | 33 | 2025 | 89244 | 0.440 |
Why?
|
Population Surveillance | 4 | 2020 | 2597 | 0.440 |
Why?
|
Weight Gain | 1 | 2024 | 2359 | 0.440 |
Why?
|
Immunization Programs | 1 | 2016 | 267 | 0.430 |
Why?
|
Ethics, Medical | 1 | 2018 | 785 | 0.410 |
Why?
|
Child | 30 | 2025 | 80960 | 0.410 |
Why?
|
Pregnancy | 27 | 2024 | 30265 | 0.410 |
Why?
|
Government | 3 | 2023 | 161 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.410 |
Why?
|
Rhodnius | 1 | 2012 | 4 | 0.410 |
Why?
|
Triatoma | 1 | 2012 | 10 | 0.400 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.400 |
Why?
|
Chemoprevention | 1 | 2014 | 326 | 0.400 |
Why?
|
Policy Making | 1 | 2016 | 546 | 0.400 |
Why?
|
Vaginal Fistula | 3 | 2016 | 16 | 0.380 |
Why?
|
Prevalence | 17 | 2024 | 15879 | 0.380 |
Why?
|
Adult | 47 | 2025 | 223851 | 0.370 |
Why?
|
Organizations | 2 | 2023 | 172 | 0.370 |
Why?
|
Social Class | 2 | 2015 | 2009 | 0.360 |
Why?
|
Pregnant Women | 4 | 2023 | 576 | 0.360 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2018 | 1360 | 0.360 |
Why?
|
Culex | 1 | 2010 | 18 | 0.360 |
Why?
|
Schools | 4 | 2021 | 1498 | 0.350 |
Why?
|
Marketing | 1 | 2012 | 224 | 0.350 |
Why?
|
Death | 1 | 2015 | 683 | 0.350 |
Why?
|
Microcephaly | 4 | 2020 | 426 | 0.350 |
Why?
|
Water | 1 | 2016 | 1421 | 0.350 |
Why?
|
Sports | 1 | 2016 | 703 | 0.340 |
Why?
|
Counseling | 1 | 2018 | 1554 | 0.340 |
Why?
|
Employment | 1 | 2016 | 1114 | 0.340 |
Why?
|
Middle Aged | 35 | 2025 | 223737 | 0.340 |
Why?
|
Health Personnel | 5 | 2023 | 3383 | 0.330 |
Why?
|
Parasite Egg Count | 1 | 2009 | 29 | 0.330 |
Why?
|
Family Planning Services | 1 | 2012 | 279 | 0.330 |
Why?
|
Gardening | 1 | 2009 | 18 | 0.330 |
Why?
|
Cost-Benefit Analysis | 5 | 2024 | 5544 | 0.320 |
Why?
|
Cluster Analysis | 4 | 2023 | 2732 | 0.320 |
Why?
|
Malawi | 2 | 2020 | 312 | 0.320 |
Why?
|
Health Surveys | 3 | 2017 | 4055 | 0.310 |
Why?
|
Overweight | 1 | 2020 | 2448 | 0.310 |
Why?
|
Geography | 5 | 2020 | 654 | 0.300 |
Why?
|
Male | 52 | 2025 | 365203 | 0.300 |
Why?
|
Pregnancy Outcome | 2 | 2019 | 2974 | 0.300 |
Why?
|
Microscopy | 3 | 2024 | 910 | 0.290 |
Why?
|
Antimalarials | 1 | 2014 | 909 | 0.290 |
Why?
|
Health Status Disparities | 2 | 2020 | 1886 | 0.290 |
Why?
|
Peru | 7 | 2025 | 891 | 0.280 |
Why?
|
Pyrethrins | 2 | 2020 | 47 | 0.280 |
Why?
|
Seasons | 4 | 2021 | 1524 | 0.270 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2013 | 843 | 0.270 |
Why?
|
Disabled Persons | 1 | 2016 | 1210 | 0.270 |
Why?
|
Needs Assessment | 1 | 2012 | 1143 | 0.270 |
Why?
|
Aged | 22 | 2025 | 171786 | 0.260 |
Why?
|
Bayes Theorem | 7 | 2024 | 2360 | 0.260 |
Why?
|
Computational Biology | 2 | 2024 | 3562 | 0.250 |
Why?
|
Animals | 25 | 2023 | 169335 | 0.250 |
Why?
|
Rifampin | 2 | 2024 | 351 | 0.250 |
Why?
|
Pregnancy Complications | 5 | 2021 | 2974 | 0.250 |
Why?
|
Cross-Sectional Studies | 18 | 2025 | 26395 | 0.250 |
Why?
|
Neglected Diseases | 2 | 2019 | 67 | 0.250 |
Why?
|
Primary Health Care | 2 | 2021 | 4748 | 0.240 |
Why?
|
Cesarean Section | 1 | 2014 | 1426 | 0.240 |
Why?
|
Hemorrhagic Fever, Ebola | 2 | 2020 | 424 | 0.240 |
Why?
|
Indonesia | 2 | 2016 | 131 | 0.240 |
Why?
|
Mammography | 1 | 2015 | 2434 | 0.240 |
Why?
|
New York City | 2 | 2020 | 737 | 0.230 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3421 | 0.230 |
Why?
|
Cities | 4 | 2021 | 543 | 0.230 |
Why?
|
Climate Change | 2 | 2020 | 509 | 0.220 |
Why?
|
Nutritional Status | 2 | 2024 | 1627 | 0.210 |
Why?
|
Arbovirus Infections | 1 | 2023 | 21 | 0.210 |
Why?
|
Aged, 80 and over | 12 | 2024 | 59739 | 0.210 |
Why?
|
Incidence | 11 | 2025 | 21547 | 0.210 |
Why?
|
Depression | 2 | 2024 | 8231 | 0.210 |
Why?
|
Quality of Life | 1 | 2024 | 13510 | 0.210 |
Why?
|
Life Tables | 1 | 2023 | 368 | 0.210 |
Why?
|
Rwanda | 3 | 2025 | 673 | 0.210 |
Why?
|
Mental Health | 5 | 2024 | 3275 | 0.200 |
Why?
|
Cohort Studies | 14 | 2024 | 41808 | 0.200 |
Why?
|
Plasmodium falciparum | 6 | 2024 | 1741 | 0.200 |
Why?
|
Clubfoot | 1 | 2023 | 87 | 0.200 |
Why?
|
Birth Weight | 3 | 2022 | 2121 | 0.200 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2022 | 2203 | 0.200 |
Why?
|
Sex Factors | 5 | 2021 | 10633 | 0.190 |
Why?
|
Directly Observed Therapy | 2 | 2024 | 139 | 0.190 |
Why?
|
Aquaculture | 1 | 2021 | 28 | 0.190 |
Why?
|
Risk Factors | 14 | 2025 | 74976 | 0.190 |
Why?
|
Economic Recession | 1 | 2022 | 79 | 0.190 |
Why?
|
Antitubercular Agents | 3 | 2024 | 1397 | 0.190 |
Why?
|
Guyana | 1 | 2021 | 17 | 0.190 |
Why?
|
Public Policy | 2 | 2023 | 552 | 0.190 |
Why?
|
Pesticides | 1 | 2024 | 298 | 0.190 |
Why?
|
Venezuela | 1 | 2021 | 73 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2013 | 4056 | 0.190 |
Why?
|
Housing | 2 | 2019 | 683 | 0.180 |
Why?
|
Prisoners | 1 | 2024 | 316 | 0.180 |
Why?
|
Markov Chains | 1 | 2024 | 979 | 0.180 |
Why?
|
Pest Control, Biological | 1 | 2020 | 21 | 0.180 |
Why?
|
Rivers | 1 | 2020 | 65 | 0.180 |
Why?
|
Leisure Activities | 1 | 2022 | 310 | 0.170 |
Why?
|
Home Childbirth | 1 | 2020 | 55 | 0.170 |
Why?
|
Antibodies, Protozoan | 1 | 2021 | 251 | 0.170 |
Why?
|
Urbanization | 1 | 2020 | 100 | 0.170 |
Why?
|
Environmental Exposure | 3 | 2023 | 4544 | 0.170 |
Why?
|
HIV Infections | 4 | 2024 | 17591 | 0.170 |
Why?
|
Vaccination | 2 | 2023 | 3438 | 0.170 |
Why?
|
Premature Birth | 2 | 2023 | 1830 | 0.170 |
Why?
|
Parenting | 2 | 2023 | 709 | 0.170 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2024 | 372 | 0.170 |
Why?
|
Geographic Information Systems | 3 | 2014 | 283 | 0.160 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 89 | 0.160 |
Why?
|
Crowding | 1 | 2020 | 144 | 0.160 |
Why?
|
Prenatal Care | 3 | 2023 | 1162 | 0.160 |
Why?
|
Gold | 1 | 2023 | 488 | 0.160 |
Why?
|
Anthropometry | 1 | 2024 | 1345 | 0.160 |
Why?
|
Night Blindness | 1 | 2019 | 58 | 0.160 |
Why?
|
Depression, Postpartum | 1 | 2024 | 355 | 0.160 |
Why?
|
Disease Notification | 1 | 2019 | 95 | 0.160 |
Why?
|
Diagnostic Tests, Routine | 1 | 2024 | 790 | 0.160 |
Why?
|
New York | 2 | 2024 | 884 | 0.150 |
Why?
|
Vitamin A Deficiency | 1 | 2018 | 88 | 0.150 |
Why?
|
El Salvador | 1 | 2018 | 34 | 0.150 |
Why?
|
Acculturation | 1 | 2020 | 179 | 0.150 |
Why?
|
Retrospective Studies | 8 | 2025 | 81903 | 0.150 |
Why?
|
Republic of Korea | 1 | 2020 | 592 | 0.150 |
Why?
|
Demography | 3 | 2020 | 1642 | 0.150 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2020 | 294 | 0.150 |
Why?
|
Africa South of the Sahara | 3 | 2016 | 753 | 0.150 |
Why?
|
Democratic Republic of the Congo | 2 | 2020 | 87 | 0.150 |
Why?
|
Obesity | 2 | 2020 | 13091 | 0.150 |
Why?
|
Treatment Failure | 1 | 2024 | 2664 | 0.150 |
Why?
|
Child Development | 2 | 2020 | 2336 | 0.150 |
Why?
|
Social Mobility | 1 | 2017 | 30 | 0.150 |
Why?
|
Laboratories | 1 | 2021 | 463 | 0.150 |
Why?
|
Criminal Law | 1 | 2018 | 97 | 0.140 |
Why?
|
Breast Neoplasms | 3 | 2025 | 21188 | 0.140 |
Why?
|
Public Health | 4 | 2020 | 2680 | 0.140 |
Why?
|
Moral Obligations | 1 | 2018 | 91 | 0.140 |
Why?
|
Environmental Monitoring | 4 | 2014 | 1469 | 0.140 |
Why?
|
Models, Biological | 2 | 2014 | 9499 | 0.140 |
Why?
|
Temperature | 2 | 2020 | 2235 | 0.140 |
Why?
|
Longitudinal Studies | 4 | 2019 | 14794 | 0.140 |
Why?
|
Laos | 1 | 2016 | 27 | 0.140 |
Why?
|
Papua New Guinea | 1 | 2016 | 47 | 0.140 |
Why?
|
Parasitemia | 1 | 2017 | 166 | 0.140 |
Why?
|
Drug Resistance | 1 | 2022 | 1599 | 0.130 |
Why?
|
Parasitology | 1 | 2016 | 28 | 0.130 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2024 | 944 | 0.130 |
Why?
|
World Health Organization | 1 | 2022 | 1328 | 0.130 |
Why?
|
Hearing Disorders | 1 | 2016 | 126 | 0.130 |
Why?
|
Haemophilus Infections | 1 | 2016 | 94 | 0.130 |
Why?
|
Diabetes Complications | 1 | 2023 | 1320 | 0.130 |
Why?
|
Early Detection of Cancer | 2 | 2024 | 3238 | 0.130 |
Why?
|
Massachusetts | 2 | 2020 | 8894 | 0.130 |
Why?
|
Carbon Monoxide | 1 | 2019 | 559 | 0.130 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2019 | 395 | 0.130 |
Why?
|
Poverty Areas | 1 | 2017 | 269 | 0.130 |
Why?
|
Speech Disorders | 1 | 2016 | 180 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2021 | 718 | 0.120 |
Why?
|
Gambia | 1 | 2015 | 104 | 0.120 |
Why?
|
Community-Institutional Relations | 1 | 2016 | 209 | 0.120 |
Why?
|
Nitriles | 1 | 2020 | 990 | 0.120 |
Why?
|
Qualitative Research | 3 | 2016 | 3143 | 0.120 |
Why?
|
Time Factors | 7 | 2021 | 40261 | 0.120 |
Why?
|
Ultrasonography, Prenatal | 1 | 2023 | 1771 | 0.120 |
Why?
|
Maternal Health Services | 1 | 2020 | 472 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
Africa | 1 | 2016 | 726 | 0.110 |
Why?
|
Dogs | 2 | 2020 | 3845 | 0.110 |
Why?
|
Water Supply | 2 | 2020 | 204 | 0.110 |
Why?
|
Disease | 1 | 2019 | 673 | 0.110 |
Why?
|
Social Responsibility | 1 | 2016 | 384 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2019 | 744 | 0.110 |
Why?
|
Occupational Exposure | 1 | 2024 | 1807 | 0.110 |
Why?
|
Government Regulation | 1 | 2018 | 525 | 0.110 |
Why?
|
State Medicine | 1 | 2015 | 219 | 0.110 |
Why?
|
Cholera | 1 | 2020 | 754 | 0.110 |
Why?
|
Data Collection | 1 | 2022 | 3324 | 0.110 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 955 | 0.110 |
Why?
|
Religion | 1 | 2016 | 376 | 0.110 |
Why?
|
Marijuana Smoking | 1 | 2016 | 261 | 0.100 |
Why?
|
Regression Analysis | 3 | 2015 | 6346 | 0.100 |
Why?
|
Movement Disorders | 1 | 2016 | 464 | 0.100 |
Why?
|
Birth Intervals | 1 | 2012 | 55 | 0.100 |
Why?
|
HIV | 1 | 2019 | 1597 | 0.100 |
Why?
|
Asymptomatic Infections | 2 | 2024 | 136 | 0.100 |
Why?
|
Postpartum Period | 1 | 2019 | 1198 | 0.100 |
Why?
|
Recurrence | 1 | 2024 | 8513 | 0.100 |
Why?
|
Social Justice | 1 | 2016 | 486 | 0.100 |
Why?
|
Parasitic Diseases | 1 | 2012 | 76 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 500 | 0.100 |
Why?
|
Guatemala | 1 | 2012 | 161 | 0.090 |
Why?
|
Contraceptive Agents | 1 | 2012 | 148 | 0.090 |
Why?
|
Prospective Studies | 8 | 2024 | 54962 | 0.090 |
Why?
|
Seroepidemiologic Studies | 2 | 2022 | 405 | 0.090 |
Why?
|
Mali | 1 | 2010 | 51 | 0.090 |
Why?
|
Logistic Models | 4 | 2020 | 13318 | 0.090 |
Why?
|
Madagascar | 2 | 2021 | 111 | 0.090 |
Why?
|
Freshwater Biology | 1 | 2010 | 1 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3629 | 0.090 |
Why?
|
Insecticide-Treated Bednets | 1 | 2010 | 70 | 0.090 |
Why?
|
Developing Countries | 1 | 2023 | 2911 | 0.090 |
Why?
|
Medically Uninsured | 1 | 2015 | 841 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12095 | 0.090 |
Why?
|
Age Factors | 2 | 2019 | 18435 | 0.080 |
Why?
|
Heart Diseases | 1 | 2023 | 2819 | 0.080 |
Why?
|
Benchmarking | 1 | 2016 | 1059 | 0.080 |
Why?
|
Neoplasm Staging | 1 | 2025 | 11262 | 0.080 |
Why?
|
India | 1 | 2016 | 2334 | 0.080 |
Why?
|
Cost Savings | 1 | 2015 | 915 | 0.080 |
Why?
|
Attitude to Health | 1 | 2018 | 2025 | 0.080 |
Why?
|
Health Care Costs | 1 | 2022 | 3270 | 0.080 |
Why?
|
Vision Disorders | 1 | 2016 | 1093 | 0.080 |
Why?
|
Mental Disorders | 2 | 2021 | 6876 | 0.080 |
Why?
|
Language | 1 | 2018 | 1559 | 0.080 |
Why?
|
Workplace | 1 | 2015 | 873 | 0.080 |
Why?
|
Mass Screening | 1 | 2024 | 5457 | 0.080 |
Why?
|
Interviews as Topic | 1 | 2016 | 2744 | 0.080 |
Why?
|
Gestational Age | 3 | 2023 | 3621 | 0.070 |
Why?
|
Fetal Development | 2 | 2023 | 777 | 0.070 |
Why?
|
Topography, Medical | 1 | 2007 | 37 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2021 | 3800 | 0.070 |
Why?
|
Culicidae | 1 | 2007 | 111 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2021 | 5369 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6086 | 0.070 |
Why?
|
Registries | 2 | 2022 | 8384 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2649 | 0.070 |
Why?
|
Antibodies, Viral | 3 | 2022 | 3215 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10592 | 0.070 |
Why?
|
Computer Simulation | 1 | 2020 | 6291 | 0.070 |
Why?
|
Focus Groups | 1 | 2012 | 1462 | 0.070 |
Why?
|
History, 21st Century | 2 | 2024 | 1575 | 0.070 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4568 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2013 | 2437 | 0.060 |
Why?
|
Insurance, Health | 1 | 2018 | 2518 | 0.060 |
Why?
|
Pregnancy Trimester, Third | 2 | 2019 | 586 | 0.060 |
Why?
|
Hemoglobins | 2 | 2024 | 1531 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3269 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5892 | 0.060 |
Why?
|
Ambulatory Care Facilities | 1 | 2010 | 941 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6982 | 0.060 |
Why?
|
Ghana | 2 | 2016 | 333 | 0.060 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3250 | 0.060 |
Why?
|
United States | 4 | 2023 | 73186 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2019 | 4576 | 0.050 |
Why?
|
Endemic Diseases | 1 | 2024 | 191 | 0.050 |
Why?
|
Blood Pressure | 1 | 2019 | 8544 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 2 | 2024 | 1930 | 0.050 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2024 | 211 | 0.050 |
Why?
|
Alcohol Drinking | 1 | 2016 | 4045 | 0.050 |
Why?
|
Particulate Matter | 1 | 2014 | 2615 | 0.050 |
Why?
|
Cancer Care Facilities | 1 | 2025 | 428 | 0.050 |
Why?
|
Exanthema | 2 | 2017 | 503 | 0.050 |
Why?
|
Diet | 1 | 2020 | 8088 | 0.050 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2023 | 161 | 0.050 |
Why?
|
Educational Status | 2 | 2021 | 2515 | 0.050 |
Why?
|
City Planning | 1 | 2020 | 14 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10847 | 0.050 |
Why?
|
Forecasting | 2 | 2020 | 2945 | 0.050 |
Why?
|
Fisheries | 1 | 2021 | 48 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3928 | 0.050 |
Why?
|
Bangladesh | 1 | 2023 | 742 | 0.050 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2021 | 112 | 0.050 |
Why?
|
Human Activities | 1 | 2020 | 26 | 0.050 |
Why?
|
Rain | 1 | 2020 | 60 | 0.040 |
Why?
|
Turkey | 1 | 2021 | 256 | 0.040 |
Why?
|
Bacillus thuringiensis | 1 | 2020 | 12 | 0.040 |
Why?
|
Bacillaceae | 1 | 2020 | 5 | 0.040 |
Why?
|
Unemployment | 1 | 2022 | 211 | 0.040 |
Why?
|
Blood Donors | 1 | 2022 | 344 | 0.040 |
Why?
|
Biology | 1 | 2022 | 292 | 0.040 |
Why?
|
Air Pollutants | 1 | 2014 | 2915 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12562 | 0.040 |
Why?
|
Science | 1 | 2002 | 236 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2015 | 4339 | 0.040 |
Why?
|
Micronutrients | 1 | 2023 | 390 | 0.040 |
Why?
|
Public Sector | 1 | 2021 | 266 | 0.040 |
Why?
|
Remote Sensing Technology | 1 | 2020 | 93 | 0.040 |
Why?
|
Sierra Leone | 1 | 2020 | 171 | 0.040 |
Why?
|
Scotland | 1 | 2019 | 142 | 0.040 |
Why?
|
Parturition | 1 | 2023 | 456 | 0.040 |
Why?
|
Education, Medical | 1 | 2011 | 1742 | 0.040 |
Why?
|
Blood | 1 | 2021 | 599 | 0.040 |
Why?
|
Models, Theoretical | 2 | 2019 | 3580 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 24333 | 0.040 |
Why?
|
Growth Disorders | 1 | 2023 | 635 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2024 | 1967 | 0.040 |
Why?
|
Contact Tracing | 1 | 2020 | 275 | 0.040 |
Why?
|
Capacity Building | 1 | 2020 | 265 | 0.040 |
Why?
|
Kenya | 1 | 2020 | 758 | 0.040 |
Why?
|
DNA, Protozoan | 1 | 2018 | 227 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 1 | 2024 | 1063 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2024 | 1741 | 0.030 |
Why?
|
Multilevel Analysis | 1 | 2017 | 148 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2022 | 1528 | 0.030 |
Why?
|
Gender Identity | 1 | 2002 | 770 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2019 | 1002 | 0.030 |
Why?
|
Physicians, Women | 1 | 2002 | 521 | 0.030 |
Why?
|
Body Mass Index | 3 | 2022 | 13055 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15661 | 0.030 |
Why?
|
Folic Acid | 1 | 2023 | 1338 | 0.030 |
Why?
|
Circumcision, Female | 1 | 2016 | 33 | 0.030 |
Why?
|
Vitamin A | 1 | 2018 | 611 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10115 | 0.030 |
Why?
|
Students | 2 | 2016 | 1744 | 0.030 |
Why?
|
Cephalometry | 1 | 2016 | 380 | 0.030 |
Why?
|
Pilot Projects | 2 | 2020 | 8748 | 0.030 |
Why?
|
Senegal | 1 | 2015 | 256 | 0.030 |
Why?
|
Vitamins | 1 | 2023 | 1638 | 0.030 |
Why?
|
Burkina Faso | 1 | 2014 | 88 | 0.030 |
Why?
|
Uganda | 1 | 2019 | 1361 | 0.030 |
Why?
|
China | 1 | 2020 | 2395 | 0.030 |
Why?
|
Iron | 1 | 2023 | 1814 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22389 | 0.030 |
Why?
|
Odds Ratio | 2 | 2016 | 9684 | 0.030 |
Why?
|
Sex Offenses | 1 | 2016 | 357 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1738 | 0.020 |
Why?
|
Body Height | 1 | 2018 | 1569 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2012 | 367 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2020 | 873 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2016 | 619 | 0.020 |
Why?
|
Boston | 2 | 2016 | 9377 | 0.020 |
Why?
|
Environment Design | 1 | 2012 | 174 | 0.020 |
Why?
|
Syndrome | 1 | 2016 | 3274 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2023 | 3443 | 0.020 |
Why?
|
Ultrasonography | 1 | 2023 | 6002 | 0.020 |
Why?
|
Calcium | 1 | 2023 | 5792 | 0.020 |
Why?
|
Students, Medical | 1 | 2002 | 1964 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3112 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6547 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3904 | 0.020 |
Why?
|
Biomedical Research | 1 | 2002 | 3463 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 65480 | 0.020 |
Why?
|
Disease Progression | 1 | 2024 | 13674 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22296 | 0.020 |
Why?
|
Exercise | 1 | 2022 | 5954 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9621 | 0.010 |
Why?
|
International Cooperation | 1 | 2011 | 1436 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3908 | 0.010 |
Why?
|
Sex Distribution | 1 | 2002 | 2280 | 0.010 |
Why?
|
Brain | 1 | 2017 | 27453 | 0.010 |
Why?
|